Europe
Pneumagen Ltd, focused on treating infectious disease and oncology by targeting the human glycome, announced promising in vivo data in oncology from a novel Carbohydrate Binding Module generated from its proprietary GlycoTarge™ platform.
Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of recombinant subunit vaccines
Lonza’s Ibex™ Design planned to take Genmab’s pre-clinical candidates from gene to potential IND within 12 months
Biocair, a global leader in specialist logistics, announced that its Frankfurt office has joined the company’s network of ISO 9001:2015 certified operations.
Alzheimer’s Research UK has responded to an announcement that could see new legislation aimed at providing faster access to medicines.
Last Friday, CELLINK and its four co-founders were awarded the prestigious award, Entrepreneur of the Year in Sweden, 2019.
The Dutch company Xenikos B.V. announced that the U.S. Food and Drug Administration has granted Fast Track designation to T-Guard, Xenikos’ flagship product designed to treat steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.
This 25th anniversary BIO-Europe® international partnering conference, November 11–13 in Hamburg, Germany, will focus on top industry visions for the next 25 years while taking a look at the most formative turning points in the past two and a half decades.
The European Investment Bank and ISA Pharmaceuticals have signed a EUR 20 million loan agreement to support the development of ISA’s therapy for cancers caused by the Human Papillomavirus type 16
Professor Lorraine Brennan from University College Dublin is delighted to have been awarded a US-Ireland grant, funded by the Health Research Board (HRB), to the tune of almost €1 million.
PRESS RELEASES